We first used the nonmalignant MCF10A cells, the M1 cells in the breast cancer progression model (Dawson et al., 1996; Santner et al., 2001) to investigate the effect of TGF-β1/TNF-α treatment on their neutrophil recruitment ability. The gene discussed is TGFB1; the disease is breast cancer.